Skip to main content
. 2023 Jul 11;10:1159960. doi: 10.3389/fmed.2023.1159960

Table 3.

Risk factors of included studies.

Factor Note No. of studies that reported this factor Meta-analysis Risk 95% CI p
Age Years 3 Yes WMD = 1.9 (−1.2, 5.8) 0.229
Gender Male/female 4 Yes OR = 1.258 (0.922, 1.717) 0.148
ASA ≥ 3 3 Yes OR = 1.570 (1.015, 2.429) 0.043
Major resection 3 Yes OR = 2.028 (1.014, 4.059) 0.046
Extended resection 1 No OR = 4.079 (2. 177, 7.642) < 0.0001
Current smoker 1 No RR = 2.21 (1. 10, 4.46) 0.027
High ALT/GPT More than 67 IU/L in men and more than 55 IU/L in women 1 No RR = 3.55 (1.68, 7.49) 0.001
Blood loss during operation Grams 2 No WMD = 505.0 (354.2, 655.9) < 0.0001
Blood transfusion 2 No OR = 2.042 (0.429, 9.719) 0.370
Operation time Minutes 2 No WMD = 89.3 (−13. 1, 191.7) 0.087
Chemotherapy 2 No OR = 1.182 (0.814, 1.715) 0.879
BMI 1 No OR = 0.997 (0.930, 1.068) 0.924
Low albumin ≤30 g/L 1 No OR = 2.420 (0.989, 5.922) 0.053
High bilirubin ≥20 μmol/L 1 No OR = 1.850 (0.931, 3.676) 0.079
Pringle maneuvre 1 No OR = 1.559 (0.835, 2.911) 0.163
Caudate lobe resection 1 No OR = 0.569 (0. 131, 2.468) 0.759
Repeat hepatectomy 1 No OR = 1.439 (0.716, 3. 111) 0.285
Central resection 1 No OR = 1.352 (0.381,4.795) 0.640
Thoracotomy 1 No OR = 1.27 (0.37,5.91) 0.721
Hepaticojejunostomy 1 No OR = 1.34 (0.45,3.97) 0.596